Literature DB >> 2837759

Synthetic peptides as substrates and inhibitors of a retroviral protease.

M Kotler1, R A Katz, W Danho, J Leis, A M Skalka.   

Abstract

Processing of the gag and pol gene precursor proteins of retroviruses is essential for infectivity and is directed by a viral protease that is itself included in one of these precursors. We demonstrate here that small synthetic peptides can be used as both model substrates and inhibitors to investigate the specificity and molecular parameters of the reaction. The results indicate that a peptide that extends five amino acids but not three amino acids in both directions from a known cleavage site is accurately hydrolyzed by the protease of avian sarcoma-leukosis virus. Substitutions of the amino acids to either side of the peptide bond to be cleaved affect the ability of the peptide (as well as a larger precursor protein) to serve as a substrate. The specificity is more stringent for the amino acid that will become the carboxyl end after cleavage. Some substitutions produced peptides that were not cleaved but could act as inhibitors of cleavage of a susceptible peptide. Thus, small model substrates may be used to explore both the binding and catalytic properties of these important proteases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837759      PMCID: PMC280391          DOI: 10.1073/pnas.85.12.4185

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Biochemical properties of p15-associated protease in an avian RNA tumor virus.

Authors:  K J Dittmar; K Moelling
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

2.  Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor.

Authors:  I Katoh; T Yasunaga; Y Ikawa; Y Yoshinaka
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  In vitro cleavage of avian retrovirus gag proteins by viral protease p15.

Authors:  V M Vogt; A Wight; R Eisenman
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

4.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  Maturation of Moloney murine leukemia virus.

Authors:  A H Lu; M M Soong; P K Wong
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

6.  A comparison of avian and murine retrovirus polyprotein cleavage activities.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

7.  Structure of and alterations to defective murine sarcoma virus particles lacking envelope proteins and core polyprotein cleavage.

Authors:  A Demsey; F Collins; D Kawka
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

8.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

9.  Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses.

Authors:  R N Eisenman; W S Mason; M Linial
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Effect of p15-associated protease from an avian RNA tumor virus on avian virus-specific polyprotein precursors.

Authors:  K Moelling; A Scott; K E Dittmar; M Owada
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

View more
  22 in total

1.  Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases.

Authors:  D D Loeb; C A Hutchison; M H Edgell; W G Farmerie; R Swanstrom
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition.

Authors:  F Preugschat; E M Lenches; J H Strauss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.

Authors:  R J Tritch; Y E Cheng; F H Yin; S Erickson-Viitanen
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 5.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

Review 6.  Resistance to human immunodeficiency virus type 1 protease inhibitors.

Authors:  D Boden; M Markowitz
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.

Authors:  K Partin; H G Kräusslich; L Ehrlich; E Wimmer; C Carter
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

8.  Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations.

Authors:  Stefano Piana; Paolo Carloni; Ursula Rothlisberger
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

9.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly.

Authors:  R P Bennett; S Rhee; R C Craven; E Hunter; J W Wills
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.